The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life

L. A. Drake, D. L. Patrick, P. Fleckman, J. Andre, R. Baran, E. Haneke, C. Sapede, Antonella Tosti

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

Background: Onychomycosis is a widespread refractory disease deleteriously affecting quality of life via social stigma and disrupting daily activities. Many physicians perceive onychomycosis as a cosmetic rather than a medical problem. Objective: Our purpose was to develop a questionnaire-based instrument to quantify the impact of onychomycosis on patients' quality of life. Methods: The questionnaire was developed and validated in a multinational cross-sectional study. Completed questionnaires from 532 patients were analyzed: 284 toenail, 248 fingernail (onychomycosis or paronychia). Results: The degree of quality of life impairment from onychomycosis varied by country studied, possibly reflecting cross-national health perception differences. Longer duration of disease, greater involvement of individual nails, and greater number of nails involved were associated with more serious adverse effects. Many physicians underestimated the associated degree of pain. Conclusion: The study confirms that onychomycosis physically and psychologically affects patients' lives. The questionnaire may be a valuable tool in evaluating the effect of therapeutic agents on quality of life of patients with onychomycosis.

Original languageEnglish
Pages (from-to)189-196
Number of pages8
JournalJournal of the American Academy of Dermatology
Volume41
Issue number2 I
DOIs
StatePublished - Aug 20 1999
Externally publishedYes

Fingerprint

Onychomycosis
Quality of Life
Nails
Paronychia
Social Stigma
Physicians
Therapeutic Uses
Surveys and Questionnaires
Cosmetics
Cross-Sectional Studies
Pain
Health

ASJC Scopus subject areas

  • Dermatology

Cite this

The impact of onychomycosis on quality of life : Development of an international onychomycosis-specific questionnaire to measure patient quality of life. / Drake, L. A.; Patrick, D. L.; Fleckman, P.; Andre, J.; Baran, R.; Haneke, E.; Sapede, C.; Tosti, Antonella.

In: Journal of the American Academy of Dermatology, Vol. 41, No. 2 I, 20.08.1999, p. 189-196.

Research output: Contribution to journalArticle

@article{78be788cd8e940c59eb92e830224d620,
title = "The impact of onychomycosis on quality of life: Development of an international onychomycosis-specific questionnaire to measure patient quality of life",
abstract = "Background: Onychomycosis is a widespread refractory disease deleteriously affecting quality of life via social stigma and disrupting daily activities. Many physicians perceive onychomycosis as a cosmetic rather than a medical problem. Objective: Our purpose was to develop a questionnaire-based instrument to quantify the impact of onychomycosis on patients' quality of life. Methods: The questionnaire was developed and validated in a multinational cross-sectional study. Completed questionnaires from 532 patients were analyzed: 284 toenail, 248 fingernail (onychomycosis or paronychia). Results: The degree of quality of life impairment from onychomycosis varied by country studied, possibly reflecting cross-national health perception differences. Longer duration of disease, greater involvement of individual nails, and greater number of nails involved were associated with more serious adverse effects. Many physicians underestimated the associated degree of pain. Conclusion: The study confirms that onychomycosis physically and psychologically affects patients' lives. The questionnaire may be a valuable tool in evaluating the effect of therapeutic agents on quality of life of patients with onychomycosis.",
author = "Drake, {L. A.} and Patrick, {D. L.} and P. Fleckman and J. Andre and R. Baran and E. Haneke and C. Sapede and Antonella Tosti",
year = "1999",
month = "8",
day = "20",
doi = "10.1016/S0190-9622(99)70047-2",
language = "English",
volume = "41",
pages = "189--196",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2 I",

}

TY - JOUR

T1 - The impact of onychomycosis on quality of life

T2 - Development of an international onychomycosis-specific questionnaire to measure patient quality of life

AU - Drake, L. A.

AU - Patrick, D. L.

AU - Fleckman, P.

AU - Andre, J.

AU - Baran, R.

AU - Haneke, E.

AU - Sapede, C.

AU - Tosti, Antonella

PY - 1999/8/20

Y1 - 1999/8/20

N2 - Background: Onychomycosis is a widespread refractory disease deleteriously affecting quality of life via social stigma and disrupting daily activities. Many physicians perceive onychomycosis as a cosmetic rather than a medical problem. Objective: Our purpose was to develop a questionnaire-based instrument to quantify the impact of onychomycosis on patients' quality of life. Methods: The questionnaire was developed and validated in a multinational cross-sectional study. Completed questionnaires from 532 patients were analyzed: 284 toenail, 248 fingernail (onychomycosis or paronychia). Results: The degree of quality of life impairment from onychomycosis varied by country studied, possibly reflecting cross-national health perception differences. Longer duration of disease, greater involvement of individual nails, and greater number of nails involved were associated with more serious adverse effects. Many physicians underestimated the associated degree of pain. Conclusion: The study confirms that onychomycosis physically and psychologically affects patients' lives. The questionnaire may be a valuable tool in evaluating the effect of therapeutic agents on quality of life of patients with onychomycosis.

AB - Background: Onychomycosis is a widespread refractory disease deleteriously affecting quality of life via social stigma and disrupting daily activities. Many physicians perceive onychomycosis as a cosmetic rather than a medical problem. Objective: Our purpose was to develop a questionnaire-based instrument to quantify the impact of onychomycosis on patients' quality of life. Methods: The questionnaire was developed and validated in a multinational cross-sectional study. Completed questionnaires from 532 patients were analyzed: 284 toenail, 248 fingernail (onychomycosis or paronychia). Results: The degree of quality of life impairment from onychomycosis varied by country studied, possibly reflecting cross-national health perception differences. Longer duration of disease, greater involvement of individual nails, and greater number of nails involved were associated with more serious adverse effects. Many physicians underestimated the associated degree of pain. Conclusion: The study confirms that onychomycosis physically and psychologically affects patients' lives. The questionnaire may be a valuable tool in evaluating the effect of therapeutic agents on quality of life of patients with onychomycosis.

UR - http://www.scopus.com/inward/record.url?scp=0032776553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032776553&partnerID=8YFLogxK

U2 - 10.1016/S0190-9622(99)70047-2

DO - 10.1016/S0190-9622(99)70047-2

M3 - Article

C2 - 10426887

AN - SCOPUS:0032776553

VL - 41

SP - 189

EP - 196

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2 I

ER -